Oncolytic viruses and pancreatic cancer
Open Access
- 16 April 2022
- journal article
- research article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 31, 100563
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancerCell Death & Disease, 2013
- Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant CellsJournal of Virology, 2011
- MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector TropismMolecular Therapy, 2011
- Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18RαGene Therapy, 2011
- SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H‐1PVInternational Journal of Cancer, 2010
- Virulence variation among isolates of western equine encephalitis virus in an outbred mouse modelJournal of General Virology, 2009
- Lister strain of vaccinia virus armed with endostatin–angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancerGene Therapy, 2009
- Anticancer activity of oncolytic adenovirus vector armed with IFN-α and ADP is enhanced by pharmacologically controlled expression of TRAILCancer Gene Therapy, 2007
- Differentially Regulated Interferon Response Determines the Outcome of Newcastle Disease Virus Infection in Normal and Tumor Cell LinesJournal of Virology, 2006
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003